scispace - formally typeset
K

Kento Imajo

Researcher at Yokohama City University

Publications -  156
Citations -  4630

Kento Imajo is an academic researcher from Yokohama City University. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Fatty liver. The author has an hindex of 28, co-authored 135 publications receiving 2949 citations.

Papers
More filters
Journal ArticleDOI

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice

TL;DR: The results suggest that ipragliflozin has a therapeutic effect on NASH with T2DM, and improve the pathogenesis of NASH by reducing insulin resistance and lipotoxicity in NASH-model mice.